| GTO ID | GTC3237 |
| Trial ID | NCT05619861 |
| Disease | B-Cell Lymphoma | B-Cell Leukemia | T-Cell Leukemia | Multiple Myeloma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Not Applicable |
| Recruitment status | Recruiting |
| Title | Clinical Study of CAR-T Technique in the Treatment of Recurrent and Refractory Hematopoietic and Lymphatic Tumor |
| Year | 2020 |
| Country | China |
| Company sponsor | Hebei Senlang Biotechnology Inc., Ltd. |
| Other ID(s) | 2022/11/09 |
| Cohort 1 | |||||||||||
|
|||||||||||